跳至主要内容
临床试验/CTRI/2018/03/012459
CTRI/2018/03/012459招募中未知

A study to assess the effect of Resveratrol-Copper (R-Cu) on levels of inflammatory cytokines in blood and tumour tissue in patients with operable stage IV squamous cell carcinoma of buccal mucosa

TMC Research Administrative Council0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or female patients 18 years and above.
  • 2. Patients who have given written informed consent
  • 3. Patients with performance status of 0,1 or 2 (ECOG scale)
  • 4. Treatment naïve operable stage IV squamous cell carcinoma of buccal mucosa patients planned for surgery.

排除标准

  • Medical comorbidities like hypertensive, diabetes mellitus, HbsAg and HIV positive, etc.

研究者

发起方
TMC Research Administrative Council

相似试验